Medical abortion doesn’t always work; it is well established that MA has an expected treatment failure rate of about 6%. Which means that as many as 1-in-17 pregnant women using abortion pills will subsequently need hospital treatment for complications arising from an incomplete abortion.
Ranbaxy (UK) Limited is the manufacturer of Medabon, the mifepristone/misoprostol combination treatment provided by BPAS to its pills-by-post clients. In its SmPC (summaries of product characteristics), Ranbaxy states that there is a non-negligible risk of treatment failure which occurs in 4.5% to 7.8% of the cases and it states clearly that women should be informed that surgical treatment may be required to achieve complete abortion.
Marie Stopes Australia reported that in 2020, 5.48% of the medical abortions it provided, failed to complete. Meaning that their clients’ pregnancies were continuing or that they had fragments of the baby and/or placenta remaining in their womb after administration of the abortion pills.
Gynuity Health Projects, a pro-abortion activist organisation, recently published results from its own study into the safety and efficacy of telemedicine abortion, in which it found that 6% of women using abortion pills at home, subsequently needed hospital treatment because of complications related to the abortion.
Freedom of Information responses from NHS Trusts in England show that 5.9% of women using medical abortion are subsequently treated in hospital for complications arising from an incomplete abortion, including retained products of conception, haemorrhage, and infection.
Matt Hancock, then Secretary of State for Health and Social Care, granted approval for abortion by phone on 30 March 2020. Since then, more than 200,000 pregnant women across England and Wales have self-managed their medical abortion at home. 12,000 have subsequently been treated at an NHS hospital for complications arising from the medical abortion treatment failure.
200,000 self-managed abortions of healthy, developing babies; andFOI Investigation
12,000 women treated in hospital for complications arising.